Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-10-05

Clinical Trial Update: Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)

View source ↗

Summary

This clinical trial update reports on the potential utility of brain natriuretic peptide (BNP) as a biomarker in ICU patients with type IV cardio-renal syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hallym University Medical Center | Conditions: Chronic Kidney Disease, Acute Heart Failure | Status: UNKNOWN